Does ABALOPARATIDE Cause Nephrolithiasis? 128 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Nephrolithiasis have been filed in association with ABALOPARATIDE (Tymlos). This represents 0.6% of all adverse event reports for ABALOPARATIDE.
128
Reports of Nephrolithiasis with ABALOPARATIDE
0.6%
of all ABALOPARATIDE reports
0
Deaths
35
Hospitalizations
How Dangerous Is Nephrolithiasis From ABALOPARATIDE?
Of the 128 reports, 35 (27.3%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABALOPARATIDE. However, 128 reports have been filed with the FAERS database.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which ABALOPARATIDE Alternatives Have Lower Nephrolithiasis Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY